In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis

Antimicrob Agents Chemother. 2007 Jan;51(1):343-5. doi: 10.1128/AAC.00742-06. Epub 2006 Oct 23.

Abstract

Reliable measures of antifungal drug susceptibility are needed. We tested the susceptibility of Cryptococcus neoformans from patients treated with amphotericin B. In vitro susceptibility employed a modified broth macrodilution method. We demonstrate a strong correlation between the quantitative measures of in vitro amphotericin B susceptibility and the quantitative response observed in patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / drug therapy
  • AIDS-Related Opportunistic Infections / microbiology*
  • Amphotericin B / pharmacology*
  • Amphotericin B / therapeutic use
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Cryptococcus neoformans / drug effects*
  • Humans
  • Meningitis, Cryptococcal / drug therapy
  • Meningitis, Cryptococcal / microbiology*
  • Microbial Sensitivity Tests
  • Regression Analysis

Substances

  • Antifungal Agents
  • Amphotericin B